4//SEC Filing
Sun BioPharma, Inc. 4
Accession 0001437749-16-043350
CIK 0001029125operating
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:01 PM ET
Size
7.7 KB
Accession
0001437749-16-043350
Insider Transaction Report
Form 4
Kellen Scott
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2016-12-12+150,000→ 150,000 totalExercise: $1.51Exp: 2026-12-12→ Common Stock (150,000 underlying) - Award
Employee Stock Option (right to buy)
2016-12-12+66,000→ 66,000 totalExercise: $1.51From: 2016-12-12Exp: 2026-12-12→ Common Stock (66,000 underlying)
Footnotes (2)
- [F1]Options scheduled to vest in eight equal installments on the last day of each calendar quarter, starting March 31, 2017.
- [F2]On December 12, 2016, the reporting person was granted an option to purchase up to 300,000 shares of common stock. The option vests proportionately based on cash proceeds received by, or contractually obligated to be remitted to, the issuer after June 1, 2016 and before December 31, 2018 from any transaction, excluding certain internal operating-related cash flows. The performance criteria was 22% satisfied on the date of grant, resulting in vesting of the option as to 66,000 shares.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001029125
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 5:01 PM ET
- Size
- 7.7 KB